Amisulpride, an atypical antipsychotic, in the treatment of acute episodes of schizophrenia: a dose‐ranging study vs. haloperidol
- 1 July 1998
- journal article
- clinical trial
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 98 (1), 65-72
- https://doi.org/10.1111/j.1600-0447.1998.tb10044.x
Abstract
This 4‐week, double‐blind, randomized study was undertaken to determine the dose‐response relationship of amisulpride in 319 patients with acute exacerbation of schizophrenia. Fixed doses of amisulpride (400, 800 and 1200 mg/day) and haloperidol (16 mg/day) were compared to amisulpride, 100 mg/day, as a potentially subtherapeutic dose. Efficacy data (BPRS total score and PANSS positive subscale) in the amisulpride groups generated a bell‐shaped dose‐response curve, with 400 mg/day and 800 mg/day being the most effective treatments for positive symptoms. Parkinsonism did not increase significantly between baseline and endpoint with amisulpride 400, 800 and 1200 mg/day compared to the amisulpride 100 mg/day group, whereas the difference was significant for haloperidol (P<0.05). It is concluded that amisulpride 400 mg and 800 mg/day is highly effective in treating the positive symptoms of schizophrenia, with less extrapyramidal side‐effects than haloperidol 16 mg/day.Keywords
This publication has 22 references indexed in Scilit:
- Amisulpride versus placebo in the medium-term treatment of the negative symptoms of schizophreniaThe British Journal of Psychiatry, 1997
- AmisulprideCNS Drugs, 1996
- Risperidone in the Treatment of Patients with Chronic Schizophrenia: a Multi-National, Multi-Centre, Double-Blind, Parallel-Group Study versus HaloperidolThe British Journal of Psychiatry, 1995
- Treatment of Negative Symptoms in Schizophrenia with AmisulprideThe British Journal of Psychiatry, 1995
- Positron Emission Tomography Studies on Dopamine Receptors in SchizophreniaClinical Neuropharmacology, 1995
- Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neurolepticsNature, 1990
- A Controlled Dose Comparison of Haloperidol in Newly Admitted Schizophrenic PatientsArchives of General Psychiatry, 1990
- A Rating Scale for Drug-Induced AkathisiaThe British Journal of Psychiatry, 1989
- The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross‐sectional study of side effects in neuroleptic‐treated patientsActa Psychiatrica Scandinavica, 1987
- A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTSActa Psychiatrica Scandinavica, 1970